BeStock  
Stocks › ABCL

AbCellera Biologics ABCL

US equityMarket cap rank #2192AI medical concept stocks
$13.78 +$0.04 (+0.29%)
Market closed · Oct 6, 2:00 am ET · Last extended-hours $13.86 +0.56%
Open$13.72
Prev close$13.74
Day range$13.21 – $13.88
Volume4.08M
Market cap$4.47B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership36.8%-2.15 pts vs. prior quarter
Institutions holding161+0 vs. prior quarter
Insider trades (recent)45 buys / 4 sellsNet buying
Short interest10.47% of floatDays to cover 9.6 · as of 15 Sep 2026
Short-sale volume share17.6%5-day average of daily volume

Short-sale volume as % of daily volume

11%14%18%21%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$14.55M (7 inflow days, 13 outflow days).

The five largest holders on file together own 38.2% of shares outstanding.

Largest holders

  • Carl Hansen17.60%
  • Baker Bros. Advisors LP10.19%
  • Capital Research4.19%
  • Two Sigma Investments, LP3.22%
  • Veronique Lecault2.97%
  • The Toronto-Dominion Bank2.95%
  • UBS Asset Management1.91%
  • Bank of America Corporation1.90%

By investor type

  • Individual/Insider21.64%
  • Hedge Fund16.29%
  • Mutual Fund13.78%
  • Public Company5.63%
  • Private Company0.61%
  • Family Office/Trust0.31%
  • Government Pension Fund0.12%
  • Sovereign Wealth Fund0.01%

Reported short interest has fallen from 15.90% to 10.47% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 33,930,287 10.5% 9.6
31 Aug 2026 34,752,708 10.7% 5.2
14 Aug 2026 41,340,862 12.8% 3.0
31 Jul 2026 48,318,516 15.8% 9.7
15 Jul 2026 45,110,268 14.8% 7.0
30 Jun 2026 48,564,126 15.9% 5.3

Discussion

No comments yet — be the first to weigh in on ABCL.

Leave a comment

Scroll to Top